RNA_Circular

Genetic Medicine Summit

Evolution Revolution

November 17 & 18, 2020

 

Registration is now closed

 

In the nearly two decades since the human genome was first sequenced, there has been an explosion of insights into the role of genetics in a vast array of diseases. Genetic medicines are a promising new class of medicine that was not possible even a short time ago.

 

Join us and let's kick-off this revolution together.

 

 

Genetic Medicine Summit Schedule

Program Highlights

Explore the rapidly advancing science and business of genetic medicines, providing participants a platform to network with colleagues, secure updates on advances in a rapidly growing field, and to attend scientific presentations given by the most esteemed global experts in the field. 

 

-Understand disease biology using Genetic Medicines as a tool.

-Watch demonstration that will enable rapid development of Genetic Medicines that are clinically       translatable.

-Meet with experts to Develop partnered drug programs.

-Learn from real case studies on how to graduate to Clinical Development with seamless translation of   pre-clinical programs to clinical manufacturing and testing.

 

Featured Speakers

Dr. Pieter Cullis, Scientific Director & CEO, NanoMedicines Innovation Network, Canada’s National Centre of Excellence in Nanomedicines, whose work has contributed to three LNP products that have been approved by regulatory agencies in the U.S. and Europe for the treatment of cancer and its complications

 

Dr. Jeffery B. Ulmer, with over 30 years experience in vaccines R&D at Merck Research Laboratories, Chiron Corporation, Novartis Vaccines and GSK

 

Dr. Michael Houghton, winner of the Nobel Prize in Physiology or Medicine 2020 for his crucial role in identifying the virus that causes hepatitis C

 

Dr. Norbert Pardi, Assistant Professor from the Perelman School of Medicine at the University of Pennsylvania and has been working on the development of universal influenza vaccines using his mRNA-based vaccine platform

 

Dr. Robin Shattock, Head of Mucosal Infection and Immunity within the Department of Medicine at Imperial College London, where his research has led to the establishment of international collaborations aimed at preclinical identification, development and selection of HIV microbicide and vaccine candidates prior to formal clinical efficacy trials

 

Dr. Sharon Wang, Vice President of Technical Development at Ultragenyx where she leads process development function for Ultragenyx products including messenger RNA, therapeutic proteins, antibodies, oligonucleotides and small molecules

 

Dr. Kurt Kamrud, Director of the Genomic Platforms Group within Science and Innovation Direction at Ceva Animal Health with over 25 years of experience in molecular virology


Stay Informed

Sign up today to automatically receive new Precision NanoSystems application notes, conference posters, relevant science publications, and webinar invites.

MENU
菜单
X
X